ORTX - Orchard Therapeutics EPS misses by $0.04 misses on revenue November, 04 2021 09:19 AM Orchard Therapeutics plc Orchard Therapeutics (NASDAQ:ORTX): Q3 GAAP EPS of -$0.29 misses by $0.04. Revenue of $1.19M (-40.5% Y/Y) misses by $3.61M. Press Release For further details see: Orchard Therapeutics EPS misses by $0.04, misses on revenue